Coastview Capital, LLC is a venture capital firm specializes in direct equity investments across all stages of companies.
Coastview Capital, LLC is a venture capital firm specializes in direct equity investments across all stages of companies. The firm primarily invests in the life sciences sector. It focuses on biopharmaceutical companies with proprietary compounds or products that have the potential to become new therapeutics and on product platform companies that use proprietary technologies to discover new drug candidates for internal development and/or partnerships. The firm invests in all geographical areas but preference is given to companies in Southern California, Boston, the San Francisco Bay area, and the greater Washington D.C. area. It typically invests between $1 million to $5 million initially and up to $10 million over the life of the company. The firm considers direct equity investments in all stages of companies. Coastview Capital, LLC is based in Los Angeles, California.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 11, 2005
Anadys Pharmaceuticals
|
Private Equity(PE) | $71.30M | Biotechnology | — |
May 26, 2005
Cylene Pharmaceuticals
|
Series B | $26.30M | Biotechnology | Yes |
Jan 21, 2004
CGI Pharmaceuticals
|
Series C | $22.30M | Biotechnology | — |
Mar 17, 2003
Hypnion
|
Series B | $47.50M | Biotechnology | — |
Coastview Capital has had 3 exits. Coastview Capital most notable exits include Anadys Pharmaceuticals , CGI Pharmaceuticals
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 17, 2011 | Anadys Pharmaceuticals | M&A | Biotechnology | Detail |
Jun 25, 2010 | CGI Pharmaceuticals | M&A | Biotechnology | Detail |
Apr 3, 2007 | Hypnion | M&A | Biotechnology | Detail |